Ophthalmology
Volume 117, Issue 9 , Pages 1667-1673, September 2010

Diagnostic Accuracy of the Heidelberg Retina Tomograph for Glaucoma:

A Population-Based Assessment

  • Paul R. Healey, MMed, PhD, FRANZCO

      Affiliations

    • Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia
    • Corresponding Author InformationCorrespondence: Paul Healey, MMed, PhD, FRANZCO, University of Sydney Department of Ophthalmology, Westmead Hospital, Hawkesbury Rd, Westmead, NSW, Australia, 2145
  • ,
  • Anne J. Lee, PhD, FRANZCO

      Affiliations

    • Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia
  • ,
  • Tin Aung, PhD, FRCSE

      Affiliations

    • Singapore Eye Research Institute, Singapore National Eye Center, Singapore
  • ,
  • Tien Y. Wong, PhD, FRCSE

      Affiliations

    • Singapore Eye Research Institute, Singapore National Eye Center, Singapore
  • ,
  • Paul Mitchell, MD, PhD, FRANZCO

      Affiliations

    • Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia

Received 25 April 2009; received in revised form 6 July 2010; accepted 6 July 2010.

Objective

To evaluate the Heidelberg Retina Tomograph II (HRTII; Heidelberg Engineering, Heidelberg, Germany) as a screening tool for open-angle glaucoma (OAG) in an older population.

Design

Population-based, cross-sectional study.

Participants

Participants from the 10-year follow-up Blue Mountains Eye Study (n = 1952; 75.6% of survivors).

Methods

Participants underwent optic nerve head imaging performed using the HRTII; OAG was diagnosed independently from optic disc photographs and Humphrey 24-2 visual fields.

Main Outcome Measures

The Moorfields Regression Analysis (MRA) was applied to scans using the default results of “normal,” borderline,” and “outside normal limits.” Outcome classification was at the person level and used data from both eyes.

Results

Mean age was 73.7 years. The HRT scans could be acquired in 1644 participants, 95.9% of those fully examined; 87.4% of scans having a topography standard deviation (TSD) ≤40 μm. Larger TSD was associated with older age and OAG. The MRA sensitivity was 64.1%, specificity 85.7%, positive predictive value 21%, and negative predictive value 97.6% for detecting OAG. Including borderline results improved sensitivity (87.0%) but specificity dropped to 70.6%. Significant predictors of abnormal MRA included OAG (odds ratio [OR], 7.70; 95% confidence interval [CI] 4.79–12.35), age (OR, 1.05; 95% CI, 1.03–1.07), TSD (OR, 1.01; 95% CI, 1.003–1.020) and disc size (OR, 3.2; 95% CI, 2.31–4.49). Diagnostic accuracy was improved by restricting TSD <40 μm. Further TSD restriction improved specificity at the expense of sensitivity. As disc size increased, specificity fell whereas sensitivity, OAG prevalence, and the proportion testing positive rose. Glaucoma prevalence, positive predictive value, and the proportion testing positive increased, but specificity fell with increasing age. Sensitivity also fell between youngest and oldest groups. Diagnostic performance improved for visual field mean deviation < −4.0 dB. Single eye analyses overestimated specificity and underestimated sensitivity compared with using data from both eyes.

Conclusions

Diagnostic test evaluation studies of HRTII using single eye analyses or restrictive selection overestimate test accuracy compared with this population-based study. Although the specificity of the MRA was inadequate for use as a glaucoma screening test, the HRTII performed relatively well in an unselected older population with acceptable quality scans in most eyes.

Financial Disclosure(s)

The authors have no proprietary or commercial interest in any of the materials discussed in this article.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Manuscript no. 2009-565.

 Financial Disclosure(s): The authors have no proprietary or commercial interest in any of the materials discussed in this article.

 Funded by the Australian National Health & Medical Research Council (Grant numbers 991407, 211069, 457349).

PII: S0161-6420(10)00716-5

doi:10.1016/j.ophtha.2010.07.001

Ophthalmology
Volume 117, Issue 9 , Pages 1667-1673, September 2010